Feb. 3 at 10:56 PM
$IOVA
From X
BIOTECH SCANNER
@BIOTECHSCANNER
·
47m
$IOVA - Keytruda(pembrolizumab) is the most commercially successful cancer drug and third in all drugs.
Lifetime estimated revenue:
1. Humira - Immunology -
$220B
2. Lipitor - Cholesterol-
$160B
3. Keytruda - Oncology-
$120B
Keytruda is an immunotherapy drug in the class of drugs called Immune Checkpoint Inhibitor (ICI). Keytruda is a miracle drug for cancer of many types. But unfortunately 50% of cancer patients still get worse after a while. There are many ICIs on the market.
In 2nd line metastatic melanoma stage 3 and 4, there’s nothing else except Amtagvi, a Tumor-Infiltrating Lymphocyte (TIL) is specifically indicated for the condition. Oncologists may use various combinations of ICIs with chemotherapy but these are not approved. It’s wide accepted because there’s no other option.
